Skip to main content
Have a personal or library account? Click to login
Endocrine Abnormalities in Patients with Chronic Kidney Disease Cover

Endocrine Abnormalities in Patients with Chronic Kidney Disease

PRILOZI
Volume 36 (2015): Issue 2 (December 2015)
By: ,   and    
Open Access
|Dec 2015
References

References

  1. 1. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003; 228: 1-14.
    Open DOISearch in Google Scholar
  2. 2. Dusso A, González EA, Martin KJ. Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab. 2011; 25: 647-55.
    Open DOISearch in Google Scholar
  3. 3. Iglesias P, Carrero JJ, Díez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol. 2012; 25: 31-42.
    Open DOISearch in Google Scholar
  4. 4. Ros S, Carrero JJ. Endocrine alterations and cardiovascular risk in CKD: Is there a link? Nefrologia. 2013; 33: 181-87.
    Search in Google Scholar
  5. 5. Carrero JJ, Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant. 2012; 27: 4030-41.
    Open DOISearch in Google Scholar
  6. 6. Holley JL. The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis. 2004; 11: 337-41.
    Open DOISearch in Google Scholar
  7. 7. Sugiya N, Nakashima A, Takasugi N, et al. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life. Osteoporos Int. 2011; 22: 1573-9.
    Open DOISearch in Google Scholar
  8. 8. Mak RH, Cheung WW, Roberts CT Jr. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res. 2008; 18: 17-25.
    Open DOISearch in Google Scholar
  9. 9. Gupta D, Gardner M, Whaley-Connell A. Role of growth hormone deficiency and treatment in chronic kidney disease. Cardiorenal Med. 2011; 1: 174-82.
    Open DOISearch in Google Scholar
  10. 10. Wiezel D, Assadi MH, Landau D, Troib A, Kachko L, Rabkin R, Segev Y. Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease. Nephrol Dial Transplant. 2014; 29: 791-9.
    Open DOISearch in Google Scholar
  11. 11. Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008; 23: 41-8.
    Open DOISearch in Google Scholar
  12. 12. Salas P, Pinto V, Rodriguez J, Zambrano MJ, Mericq V. Growth retardation in children with kidney disease. Int J Endocrinol. 2013; doi: 10.1155/2013/970946
    Open DOISearch in Google Scholar
  13. 13. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med. 2000; 343: 923-30.
    Open DOISearch in Google Scholar
  14. 14. Mehls O, Lindberg A, Nissel R, Haffner D, Hokken- Koelega A, Ranke MB. Predicting the response to growth hormone treatment in short children with chronic kidney disease. J Clin Endocrinol Metab. 2010; 95: 686-92
    Open DOISearch in Google Scholar
  15. 15. Iglesias P, Díez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009; 160: 503-15.
    Open DOISearch in Google Scholar
  16. 16. Abdel-Rahman EM, Mansour W, Holley JL. Thyroid hormone abnormalities and frailty in elderly patients with chronic kidney disease: a hypothesis. Semin Dial. 2010; 23: 317-23.
    Open DOISearch in Google Scholar
  17. 17. Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012; 16: 204-13.
    Open DOISearch in Google Scholar
  18. 18. Mohamedali M, Reddy Maddika S, Vyas A, Iyer V, Cheriyath P. Thyroid disorders and chronic kidney disease. Int J Nephrol. 2014; doi: 10.1155/2014/520281.
    Open DOISearch in Google Scholar
  19. 19. Xu G, Yan W, Li J. An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases. Clin Exp Nephrol. 2014; 18: 837-43.
    Open DOISearch in Google Scholar
  20. 20. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in endstage renal disease. Kidney Int. 2006; 70: 523-8
    Open DOISearch in Google Scholar
  21. 21. Lu Y, Ku E, Campese VM, Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Curr Hypertens Rep. 2010; 12: 303-6.
    Open DOISearch in Google Scholar
  22. 22. Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol. 2012; 2012: 691369.
    Open DOISearch in Google Scholar
  23. 23. Siew ED, Ikizler TA. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Semin Dial. 2010; 23: 378-82.
    Open DOISearch in Google Scholar
  24. 24. Adamczak M, Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol. 2013; 33: 2-13.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/prilozi-2015-0059 | Journal eISSN: 1857-8985 (formerly 0350-1914) | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English, Russian
Page range: 109 - 118
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Chronic kidney disease,
Endocrine abnormalities,
Erythropoietin
Related subjects:
Social sciences,
Education,
Education, other

© 2015 Piotr Kuczera, Marcin Adamczak, Andrzej Wiecek, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 36 (2015): Issue 2 (December 2015)
Previous article
Next article